๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

154 Overcoming Acquired Resistance to Afatinib in HCC827, a Non-small Cell Lung Cancer Cell Line

โœ Scribed by Hsu, J.; Lin, W.; Lien, T.; Chang, W.; Sun, M.; Jiang, S.; Yen, K.; Chao, Y.

Book ID
122535393
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
75 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Establishment of a human non-small cell
Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
โœ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosineโ€kinase inhibitor gefitinib (Iressaยฎ, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drugโ€resistant sublines with their parental cells are useful approaches to identifying the m

Targeting BCL-2 family proteins to overc
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer
โœ Emmanuelle Wesarg; Sandra Hoffarth; Rainer Wiewrodt; Monika Krรถll; Stefan Bieste ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 422 KB

## Abstract Cytotoxic chemotherapies are standard of care for patients suffering from advanced nonโ€small cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and longโ€term survival is rarely observed. Clinically applied anticancer drugs exert at least some of the